Document Type : Research Paper
Authors
University of Anbar - College of Medicine
10.37652/juaps.2014.123987
Abstract
One hundred and fifty seven (157) adult patients from both sexes were included in this study. Sixty(60) adult persons were presented as control groups . Patients were suffering from Urinary tract infec-tions.Urine and serum specimens were taken from each patient to be used for IgG , IgM , IgA and com-plement C3 study . Tamm Horsfall protein , IgM and IgG were studied in urine . Bacteriological investiga-tions were done for each urine specimen from patients and control groups. Sixty(60) patients were show-ing positive Urine culture , females were showing the highest ratio in all age groups particularly the first two groups(17-27) and (28-38) years old. Sera from patients of positive and negative Urine cultures were showing higher values of IgG, IgM, IgA and C3 than control . Higher values of THP were found in urine of patients with negative Urine culture and control groups . In conclusion,Tamm-Hors-fall protein,IgM, IgG and IgA are important to combat UTIs locally and systemic .
Keywords
Main Subjects
1. Schaeffer Anthony J, Schaeffer Edward M., (2012)Chapter 10”:Urinary tract infection. CAMPBELL-WALSH UROLOGY, 10thed , Philade-lphia by Saunders company.:pp:272-341.
2. Handley, M. A., Reingold, A. L., Shiboski, S. and Padian, N. S.(2002): 'Incid ence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides', Epidemiology, 13(4), 431-6.
3. Davis .Niall F and Hugh D. Flood (2011):The Pathogenesis of Urinary Tract Infections, Clinical Management of Complicated Urinary Tract Infection, Dr. Ahmad Nikibakhsh (Ed.), SBN:978-953-307-393-4,Available from:clinical mana gement of complicated urinary tract infection / the pathogenesis of urinary-tract-infections.
4 .Weichhart, T.; Zlabinger, G.J.; Saemann, M.D. (2005):The multiple functions of Tamm-Horsfall protein in human health and disease: A mystery clears up, Wien KlinWochenschr, , 117, 316-322.
5. Gersch S.Michael, Yuri Y. Sautin, Christine M. Gersch, George Henderson,Lise Bankir and Richard J. Johnson(.2006: Does Tamm–Horsfall protein–uric acid binding play a significant role in urate homeostasis?, Nephrol Dial Transplant (2006) 21: 2938–2942 .(Iraqi virtual library).
6. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, HultgrenSJ, Kumar S (2004):Tamm-hors- fall protein knockout mice are more prone tourinary tract infection: rapid communication. Kidney Int, 65:791–797. (Iraq virtual science library).
7.Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR. (2001):Tamm-Horsfall protein binds to type1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Iaand Ib receptors. J Biol Chem. Mar 30;276(13):9924-30.
8. Weichhart T., M. Haidinger, W. H. Hörl and M. D. Säemann(2008): Eur J Clin Invest; 38 (S2): 29–38.
9. Ethel S, GK Bhat, BM Hegde.(2006): Bacterial Adherence and Humoral Immune Response in Women.Indian Journal of Medical Microbiology, 24 (1):30-3.
10. Li K, Feito MJ, Sacks SH, Sheerin NS.( 2006): CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J Immunol; 177(4):2543-2551.
11. Vandepitte J.; K. Engback; P. Piot and C.C.Heuch.2003: Basics LaboratoryProcedures in Clinical Bacteriology .World Health Organization, Geneva: 37-42.
12. Forbes B. A. , Sahm D.F. , & Weissfeld A.S. (2007) : Bailey and Scott'sDiagnostic Microbiology .12th ed. Mosby Company. Missouri .,PP;842-844
13. Kunin CM, Evans C, Bartholomew D,.( 2002):The antimicrobial defense mechanism of thefemale urethra: a reassessment. J Urol;168:413–9.
14. Joseph DiPiro, R.T., Gary Yee, Gary Matzke, Barbara Wells, L. Michael Posey (2011): Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical.
15. Foxman, B(2002):Epidemiology of urinary tract infections: incidence, mor- bidity, and economic costs. Am J Med 113 (Suppl 1A):5S–13S.
16. Abdul-Ghani MA, Glicberg F, Sahagian H. (2002):High incidence of resistant patho-gens in communityacquiredbacteriuria from patients in the Jerusalem area with lower urinary tract infections. Harefuah ; 141:1032-1035.
17.Nimri Laila.(2010):CommunityAcqu- ired Urinary Tract Infections in aRural Area in Jordan: Predominant Uropathogens,And their antimicrobial Resistance.Webmed Central Microbiology; 1(9 ) :WMC00660.
18.Stephen Bent, Brahmaji, DavidL, Stephan D.(2002):Does this women have an acute uncomplicated urinary tract infection. J Am Med A ,vol:287 .No.20.
19. Hajarnis, S. (1996): Suspected Urinary tract infection: Identification of microorganisms and sensitivity to antibiotics in Seychelles. Seychelles medical and Dental journal. 1996 issue-1997 issue.P.1-32Int 2004; 66: 974–977.
20.Abdullah, Basima Ahmed; the Druze, Nadia Abbas and Al-sammak, ESRA Ghanem. (2001): Prevalence and distribution of microorganisms in the cervix and vagina inflammation in Ninawa Governorate, Al Rafidain Science magazine-folder 3, (1) life sciences, pp. 37-48.
21.AL-Jammaly.Modruka M. H. (2005): Genitourinary Tract Infections of Women in Mosul City. MSC.Thesis. University of Mosul.
22.AL-begat Saad Taha Mutlk Hmidan (2007) : Study of most common aerobic bacteria causing lower urinary tract (UTI )in Ramadi general hospital .MSC Thesis,Cllege of medicine,AL-Anbar university.
23. Jawetz, E.; Melink, J.L. and Adelberg, E.A. (2010): Review of Medical Microbiology.25rd. Lange Medical Book .Appleton and Lange California.
24.Nielubowicz. Greta R. and Mobley .Harry L. T.(2010): Host–pathogen interactions in urinary tract infection. Nat. Rev. Urol. 7, 430–441.
25.Mobley, H. L., Donnenberg, M. S. & Hagan,e.C.(2009):EcoSal-Escherichia coli and Salmonella:Cellular and Molecular Biology (eds Böck, A.et al.) ,ASM Press, Washington, DC.
26. Sean P. McLaughlin, MD, Culley C. Carson, MD. (2004) :Urinary tract infections in women. Med Clin N Am88 417–429.
27.Pizarro-Cerda´ and Pascale Cossart(2006): Bacterial Adhesion and Entry into Host Cells. Cell:124, 715–727, February 24,2006, Elsevier Inc
28. Wolday D, Erge W. (1997): Increased incidence of resistance to antimicrobals by urinarypathogens isolated at TikurAnbessa Hospital. Ethiop Med J. 35: 127-135.
29. Ronald A. (2002): The etiology of urinary tract infection: Traditional and EmergingPathogens. Am J Med 113 (1A): 14S-19S.
30. Al-Banea H. Z. , (2006) : Factors Affecting on Haemolysin Production from Pathogenic Bacteria Isolated from Diabetes Patients Urine and Its Resistance to Some Antibiotics.M.Sc.Thesis, College of Science,Al-MustansiyraUniversity.
31. Burwen, D. R., S. N. Banerjee, and R. P. Gaynes. (1994): Ceftazidime resist-ance among selected nosocomial gram-negative bacilli in the UnitedStates. J. Infect. Dis. 170:1622–1625.
32. Katherine O’Riordan and Jean C. Lee (2004):Staphylococcus aureus Capsular Polysaccharides Clinical Microbiology Reviw, AM Society for Microbiology Jan., p. 218–234 Vol. 17, No. 1.
33. Raz, R., Colodner, R., Kunin, C.M., (2005):Who Are You-Staphylococcus saprophyticus? 622 ,Clin. Infect. Dis. 40, 896-898.
34.Al-Janabi H. Abdullah Naeif, (2007) :“ Occurrence of Staphylococcus saprophyticus in Urinary Tract Infection (UTI) with focusing on its Virulence Factors ”PHD.Thesis,College of Science,Al-Anb- ar University.
35. Sharma, P. &Thapa, L. (2007): Acute pyelonephritis in pregnancy: a retrospective study.Aust N Z J Obstet Gynaecol, 47, 313-315.
36.Al-Greti Salim Hussien Hassan. (2012): Evaluation of urinary secretary immunoglobulin (sIg) level in diabetic patients at Karbala city.Kerbala Journal of Pharmaceutical Sciences No.3 .(Iraqi academic scientific Journal).
37. Gilbert, G.L., Garland, S.M., Fairley, K.F. & McDowall, D.M. (1986) : Bacteriuria due toureaplasmas and other fastidious organisms during pregnancy: prevalence andsignificance. Pediatr Infect Dis, 5, S239-243
38.Cohen, I., Veille, J.C. & Calkins, B.M. (1990): Improved pregnancy outcome followingsuccessful treatment of chlamydial infection. J AM A, 263, 3160-3163.
39.Astal, Z. El. (2005): Increasing ciprofloxacin resistance among prevalent Urinary tract bacterial isolates in Gaza strip, Palestine Journal of Biomedicine and Biotechnology, 3: 238-241.
40.Johnson JR, Kuskowski MA, Wilt TJ.(2006): Systematic review: antimicro- bial urinary cathetersto prevent catheter associated urinary tract infection in hospitalized patients. Ann Intern Med Jan 17;144(2):116-26
41.Abdul-Mehdi Ra'ad Jasim.(2010): Stu-dy of some Bacteriological and Immunological Aspects for Patients with Acute Pyelonephritis in Hilla City-Iraq. A thesis to the College of Medicine/Babylon University the Degree of Master in Medical Microbiology.
42.Male D., J. Brostoff, D. B Roth, and Roitt. I, ( 2006 ): Immunology ,7th ed. MOSBY publishers, International ed. Canada.
43.Weichhart T., M. Haidinger, W. H. Hörl and M. D. Säemann. (2008):Current concepts of molecular defence mechanisms operative during urinary tract infection, European Journal of Clinical Investigation Vol 38.
44. Sleigh, J. D., and Timbury, M. C. (1998):Notes on medical bacteriology.5th ed. Churchill Livingstone. P. 245-252.
45. AL-Ajili .Mohammed. N. K. (2002): Microbiological Study of Urinary Tract Infection in Acute Leukemic Children.MSC.Thesis. College Of Medicine , AL-Nahrain University.
46. Azat. A. Nariman F. (2012): Evaluation of Serum (immunoglobulin G, M) in children with nephrotic syndrome relapse.Fac Med Baghdad; Vol. 54, No. 1.( Iraqi academic scientific Journal).
47. Sela O, El-Roeiy A, Pick AI, ShoenfeldY. (1987) : Serum immunoglobulin levels in patients with active pulmonary tuberculosis and patients with klebsiella infection. Immunol Lett, 15:117-120.
48. Aho K, Helio¨vaara M, Knekt Pet al. (1997):Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis 1997;56:351–6.
49. Ramı´rez, A. S., A. Rosas, J. A. Herna´ndez-Beriain, J. C. Orengo, P. Saavedra,C. de la Fe, A. Ferna´ndez and J. B. Poveda.(2005): Relationship between rheumatoid arthritis and Mycoplasma pneumoniae : a case–control study Rheumatology.;44:912–914.
50. Horowitz S, Evinson B, Borer A, Horowitz J. (2000): Mycoplasma fermentans in rheumatoid arthritis and other inflammatory arthritides. J Rheumatol;27:2747–53.
51.Stamm, W. E., M. McKevitt, P. L. Roberts, and N. J. White. (1991): Natural history of recurrent urinary tract infections in women. Rev. Infect. Dis.13:77–84.
52.Price,Gregory A. Marcia M. Hobbs, and Cynthia Nau Cornelissen.(2005): Immunogenicity of Gonococcal Transferrin Binding Proteins during Natural infectionsinfection and immunity, American Society for Microbiology., p. 277–283.
53.Ricklin D., G. Hajishengallis, K. Yang, and J. D. Lambris. (2010) : “Complement: a key system for immune surveillance and homeostasis,” Nature Immunology, vol. 11, no. 9, pp. 785–797,.
54. Goldblum RM. (1990) :The role of IgA in local immune protection. J Clin Immunol;10:S65-S71.
55. Goldstein .M. F., A. L. Goldstein, E. H. Dunsky, D. J. Dvorin, G. A. Belecanech , and K. Shamir.(2006):“Selective IgM immunodeficiency:retrospective ana-lysis of 36 adult patients with review of the literature ,” Annals of Allergy, Asthma & Immunology, vol. 97, no. 6, pp. 717–730.
56. Suman E, Bhat GK, Hegde BM. (2001): Bacterial adherence and immune response in recurrent urinary tract infection. Int J Gynec Obstet ; 75 :263–8.
57. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation.Annu Rev Immunol 1993; 11 : 403-50.
58.Ostaszewska-Puchalska Iwona , Bożena Zdrodowska-Stefanow, Jerzy Badyda, Violetta Bułhak- Kozioł, Katarzyna Puciło and Barbara Darewicz. (2004): Antichlamydial antibodies in the serum and expressed prostatic secretion in prostatitis, Arch Immunol Ther Exp, pp; 52, 277–283.
59. Raffi .Hajamohideen S, Bates James M, Dayl J Flournoy and Satish Kumar. (2012):Tamm-Horsfall protein facilitates catheter associated urinary tract infection.BMC Research Notes, 5:532. (Iraqi virtual library).
60.Sejdiu I, Torffvit O. (2008): Decreased urinary concentration of Tamm–Horsfall protein is associated with development of renal failure and cardiovascular death within 20years in type 1 but not in type 2 diabetic patients. Scand J Urol Nephrol; 42: 168–174.
61. Romero MC, Zanaro N, González L, Trigo P, Imventarza O, Nesse A.(2002) :Tamm-Horsfall protein excretion to predict the onset of renal insufficiency. Clin Biochem.;35:65-68.
62. Bleyer AJ, Trachtman H, Sandhu J (2003):Renal manifestations of a mutation in the uromodulin (Tamm Horsfall protein) gene. Am J Kidney Dis; 42: E20–E26.
63. Raffi HS, Bates JM Jr, Laszik Z, Kumar S. (2005):Tamm-Horsfall protein acts as ageneral host-defense factor against bacterial cystitis. Am J Nephrol. 25(6) :570-8.
64.Kobayashi,K.; Fukuoka, S. (2001): Conditions for solubilization of Tamm-Horsfall protein /uromodulin in human urine and establishment of a sensitive and accurate enzyme-linked immunosorbent assay (ELISA) method, Arch Biochem Biophys, , 388, 113-120.
65.Devuyst O, Dahan K, Pirson Y. (2005):Tamm-Horsfall protein or uromodulin: new ideas about an old molecule. Nephrol Dial Transplant. Jul; 20(7): 1290-4
66.Wai-Hoe Lau, Wing-Seng Leong, Zhari Ismail, Lay-Harn Gam.(2008): Qualification and application of an ELISA for the determination of Tamm Horsfall Protein (THP) in human urine and its use for screening of Kidney Stone Disease.Int J Biol Sci, 4(4):215-222.
67.Carvalho M., R.A. Mulinari and Y. Nakagawa.(2002): Role of Tamm-Hors- fall protein and uromodulin in calcium oxalate crystallization. Braz J Med Biol Res 35(10)
68. James m. Bates, jr., Haja Mohideen Raffi, Krishna Prasadan, Ranjan Mascarenhas,Zoltan Laszik, Nobuyo Maeda, Scott J. Hultgren, and Satish kumar. (2004): Tamm-Horsfall protein knockout mice are moreprone to urinary tract infection Rapid Communication .Kidney International, Vol. 65 pp. 791–797.
69. Raffi HS, Bates JM Jr, Laszik Z, Kumar S.( 2009):Tamm-horsfall protein protects against urinary tract infection by proteus mirabilis. J Urol. May; 181 (5): 2332-8.
70. Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D: (2003)A UKmulticenter study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect, 46:94–100.
)
